The Vall d'Hebron University Hospital is a public and university affiliated hospital founded in 1955. It belongs to the Catalan Health Institute and is the hospital complex with the highest volume of interventions in Catalonia, Spain.

There are 1,146 beds in Headache Unit, University Hospital Vall d'Hebron.

During the past decade, Headache Unit, University Hospital Vall d'Hebron conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Headache Unit, University Hospital Vall d'Hebron" are "Migraine" (2 trials). Many other conditions were trialed in "Headache Unit, University Hospital Vall d'Hebron" in a lesser frequency.

Most popular intervention types in "Headache Unit, University Hospital Vall d'Hebron" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "gammaCore®-R" (1 trials), "gammaCore®-R Sham" (1 trials) and "non-invasive vagus nerve stimulation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Headache Unit, University Hospital Vall d'Hebron" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Headache Unit, University Hospital Vall d'Hebron". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Headache Unit, University Hospital Vall d'Hebron, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Headache Unit, University Hospital Vall d'Hebron, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".